Polycythemia Vera Case Study - Final Thoughts on Ruxolitinib

Srdan Verstovsek, MD, PhD

Srdan Verstovsek, MD, PhD of the MD Anderson Cancer Center in Houston, Texas notes that in his experience, patients with polycythemia vera who are unresponsive to hydroxyurea tend to have much improves symptoms and quality of life once they begin ruxolitinib treatment.
Printer Printing...